Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1318633.RADCsjCElYhy41C6GSiBdgBRkOXOzQbV6WD-6n2s8X8vI130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318633.RADCsjCElYhy41C6GSiBdgBRkOXOzQbV6WD-6n2s8X8vI130_provenance.
• NP1318632.RAUYlMVmyVpL-ja1VcEpxE2YMk7a2sC5T_864rDlOFkWc130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318632.RAUYlMVmyVpL-ja1VcEpxE2YMk7a2sC5T_864rDlOFkWc130_provenance.
• NP1318636.RASOvVBL3c2E1baZ4KRRoKoryvCBq-5mjeF4QInWEmt1o130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318636.RASOvVBL3c2E1baZ4KRRoKoryvCBq-5mjeF4QInWEmt1o130_provenance.
• assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1318627.RAINT_yWRkgLGn_FEp8HckmHD6gZhEIxByMrVIMF0is9Y130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318627.RAINT_yWRkgLGn_FEp8HckmHD6gZhEIxByMrVIMF0is9Y130_provenance.
• NP1318628.RAFTyKRGLtmMQr-w9lIObn7-FUo58-cSJSYwOuE6QDdP8130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318628.RAFTyKRGLtmMQr-w9lIObn7-FUo58-cSJSYwOuE6QDdP8130_provenance.
• NP1318630.RAojVLROqxWjOjBaTT3XQz23Y3U1gbeJ5lPUo4LmFadKY130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318630.RAojVLROqxWjOjBaTT3XQz23Y3U1gbeJ5lPUo4LmFadKY130_provenance.
• NP1318635.RAt-hWXkVhZof6GAYbAPsuUy7duIEwjaRsniKVcBtEitU130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318635.RAt-hWXkVhZof6GAYbAPsuUy7duIEwjaRsniKVcBtEitU130_provenance.
• NP1318637.RAt5Iw6T740I8ryqBQvPaJOGvSuzz3RHc2pH3Lbjz0NMk130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318637.RAt5Iw6T740I8ryqBQvPaJOGvSuzz3RHc2pH3Lbjz0NMk130_provenance.
• NP1318638.RAvUQl2gSV3BGPNL1ahBxa1oPpO0CptcAxRcnhFmG6KPk130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318638.RAvUQl2gSV3BGPNL1ahBxa1oPpO0CptcAxRcnhFmG6KPk130_provenance.
• NP1318640.RApAqQ-h25vR3cpEW1iD2OEGuCHPpKqjJeXlJ6_pkWrhI130_assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1318640.RApAqQ-h25vR3cpEW1iD2OEGuCHPpKqjJeXlJ6_pkWrhI130_provenance.
• assertion description "[We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.